BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 886206)

  • 1. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.
    Onderdonk AB; Kasper DL; Cisneros RL; Bartlett JG
    J Infect Dis; 1977 Jul; 136(1):82-9. PubMed ID: 886206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
    Kasper DL; Onderdonk AB
    Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface antigens as virulence factors in infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Polk BF; Bartlett JG
    Rev Infect Dis; 1979; 1(2):278-90. PubMed ID: 549184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of the antibody response to the capsular polysaccharide of Bacteroides fragilis in an animal model of intraabdominal abscess formation.
    Kasper DL; Onderdonk AB; Bartlett JG
    J Infect Dis; 1977 Dec; 136(6):789-95. PubMed ID: 336801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulence factors in Bacteroides fragilis group.
    Jotwani R; Gupta U
    Indian J Med Res; 1991 Jul; 93():232-5. PubMed ID: 1959952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity of Bacteroides fragilis group in rat intra-abdominal abscesses.
    Jotwani R; Gupta U; Watanabe K; Ueno K
    Microbiol Immunol; 1992; 36(10):1041-9. PubMed ID: 1479960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.
    Onderdonk AB; Shapiro ME; Finberg RW; Zaleznik DF; Kasper DL
    Rev Infect Dis; 1984; 6 Suppl 1():S91-5. PubMed ID: 6372042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide.
    Zaleznik DF; Zhang ZL; Onderdonk AB; Kasper DL
    J Infect Dis; 1986 Jul; 154(1):40-6. PubMed ID: 3711690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence of Bacteroides fragilis in vivo.
    Onderdonk AB; Moon NE; Kasper DL; Bartlett JG
    Infect Immun; 1978 Mar; 19(3):1083-7. PubMed ID: 640723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.
    Onderdonk AB; Markham RB; Zaleznik DF; Cisneros RL; Kasper DL
    J Clin Invest; 1982 Jan; 69(1):9-16. PubMed ID: 6976357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
    J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular immunity to Bacteroides fragilis capsular polysaccharide.
    Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
    J Exp Med; 1982 Apr; 155(4):1188-97. PubMed ID: 6174672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of Escherichia coli--Bacteroides fragilis pathogenic synergy in an intraabdominal infection model.
    Rotstein OD; Kao J
    Can J Microbiol; 1988 Mar; 34(3):352-7. PubMed ID: 3046726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysaccharide biosynthesis locus required for virulence of Bacteroides fragilis.
    Coyne MJ; Tzianabos AO; Mallory BC; Carey VJ; Kasper DL; Comstock LE
    Infect Immun; 2001 Jul; 69(7):4342-50. PubMed ID: 11401972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity of the Bacteroides fragilis group.
    Brook I
    Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and identification of encapsulated strains of Bacteroides fragilis.
    Kasper DL; Hayes ME; Reinap BG; Craft FO; Onderdonk AB; Polk BF
    J Infect Dis; 1977 Jul; 136(1):75-81. PubMed ID: 328787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenicity of piliated and encapsulated Bacteroides fragilis.
    Brook I; Coolbaugh JC; Walker RI
    Eur J Clin Microbiol; 1984 Jun; 3(3):207-9. PubMed ID: 6147247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain.
    Kalka-Moll WM; Wang Y; Comstock LE; Gonzalez SE; Tzianabos AO; Kasper DL
    Infect Immun; 2001 Apr; 69(4):2339-44. PubMed ID: 11254591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal model system for studying virulence of and host response to Bacteroides fragilis.
    Onderdonk AB; Cisneros RL; Finberg R; Crabb JH; Kasper DL
    Rev Infect Dis; 1990; 12 Suppl 2():S169-77. PubMed ID: 2406869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.